Buy everolimus (Afinitor)

Everolimus (Afinitor) 5 mg tablets are prescribed for advanced cancer and organ transplant support. This mTOR inhibitor helps manage certain tumors and prevents organ rejection. Always follow healthcare provider guidance when using everolimus. Not intended for self-treatment.

Strength

5 mg/1

Manufacturer / TM Owner

Novartis Pharmaceuticals Corporation

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Everolimus (Afinitor) 5 mg tablets are used to treat specific types of advanced cancers, including breast, pancreatic, and kidney cancers. It is also prescribed to prevent organ transplant rejection in kidney and heart transplant patients. Patients often ask, 'What is everolimus used for?' to understand its role in managing chronic conditions. This medication belongs to a class of drugs that help regulate cell growth and immune response.

Side Effects

Everolimus (Afinitor) 5 mg tablets work by slowing the growth of cancer cells and suppressing the immune system to prevent organ rejection. Common effects include changes in blood cell counts, digestive discomfort, and skin reactions. Some users report fatigue or mild nausea, which may vary by individual. These effects are typically monitored by a healthcare provider during treatment.

Precautions & Warnings

Everolimus (Afinitor) 5 mg tablets should be handled with care, especially by those with a history of infections or liver problems. Avoid close contact with people who are sick, as the medication may weaken the immune system. Pregnant or breastfeeding individuals should consult a doctor before use. Always store tablets in a cool, dry place away from children.

Avoid Interactions

Everolimus (Afinitor) 5 mg tablets may interact with certain medications, including strong CYP3A4 inhibitors or inducers, which can affect its effectiveness. Grapefruit and grapefruit juice should be avoided due to potential interaction risks. Alcohol use may increase side effects like dizziness or nausea. Always inform your healthcare provider about all medications and supplements you are taking.

References

Frequently Asked Questions

Everolimus (Afinitor) 5 mg tablets are used to treat advanced cancers and prevent organ transplant rejection.

Store everolimus 5 mg tablets in a cool, dry place away from children and moisture.

No, grapefruit juice may interact with everolimus and should be avoided.

Common side effects include fatigue, nausea, and changes in blood cell counts.

Everolimus may harm an unborn baby; consult a doctor before use if pregnant or breastfeeding.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.